Elevated <scp>d</scp> -2-hydroxyglutarate during colitis drives progression to colorectal cancer
Jie Han(Baylor University Medical Center), Arianne L. Theiss(Rocky Mountain MS Center), Rhonda F. Souza(Southwestern Medical Center), Beth N Cook(Baylor University Medical Center), K. Venuprasad(Southwestern Medical Center), Kevin Turner(University of Minnesota), Robert M. Genta(Union Bank of Switzerland), Dakota N. Jackson(Baylor University Medical Center), Erland Arning(Baylor University Medical Center), Xuan Wang(Tongji University), Lawrence Sweetman(Baylor University Medical Center), Janette Holm(Baylor University Medical Center), Paula Ashcraft(Baylor University Medical Center)
Cited by 56
Related Papers
Radiofrequency Ablation in Barrett's Esophagus with Dysplasia
|New England Journal of Medicine|2009|1.4k
American Gastroenterological Association Technical Review on the Management of Barrett's Esophagus
|Gastroenterology|2011|1.1k
Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline
|The American Journal of Gastroenterology|2022|476
Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis
|Molecular Cancer|2020|465
Durability of Radiofrequency Ablation in Barrett's Esophagus With Dysplasia
|Gastroenterology|2011|455